EMA gains more power to monitor medicines
The role of the European Medicines Agency (EMA) is being reinforced, as the EU is increasing its powers to monitor drug development in times of crisis. ”A stronger EMA means that we can count on a coordinated EU response in mitigating and preventing medicine and medical devices shortages,” EU officials say.
BY PETER THOMSEN EU CORRESPONDENT FOR WATCH MEDIER, TRANSLATED BY DANIEL PEDERSEN
Soon, the European Medicines Agency (EMA) will have more power to oversee European drugmaking.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
European health ministers welcome EU Commission's HERA
For subscribers
